Cargando…
Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study
The crescent evolution of a global pandemic COVID-19 and its respiratory syndrome (SARS-Cov-2) has been a constant concern (Ghosh 2021; Khan et al. 2021; Alazmi and Motwalli 2020; Vargas et al. 2020). The absence of a proven and effective medication has compelled all the scientific community to sear...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264178/ https://www.ncbi.nlm.nih.gov/pubmed/34236527 http://dx.doi.org/10.1007/s00894-021-04828-8 |
_version_ | 1783719494814793728 |
---|---|
author | Morgon, Nelson H. Grandini, Giulia S. Yoguim, Maurício I. Porto, Caio M. Santana, Lucas C. Biswas, Srijit de Souza, Aguinaldo R. |
author_facet | Morgon, Nelson H. Grandini, Giulia S. Yoguim, Maurício I. Porto, Caio M. Santana, Lucas C. Biswas, Srijit de Souza, Aguinaldo R. |
author_sort | Morgon, Nelson H. |
collection | PubMed |
description | The crescent evolution of a global pandemic COVID-19 and its respiratory syndrome (SARS-Cov-2) has been a constant concern (Ghosh 2021; Khan et al. 2021; Alazmi and Motwalli 2020; Vargas et al. 2020). The absence of a proven and effective medication has compelled all the scientific community to search for a new drug. The use of known drugs is a faster way to develop new therapies. Molecular docking is a powerful tool (Gao et al. J Mol Model 10: 44–54, 2004; Singh et al. J Mol Model 18: 39–51, 2012; Schulz-Gasch and Stahl J Mol Model 9:47–57, 2003) to study the interaction of potential drugs with SARS-CoV-2, Alsalme et al. (2020) and Sanders et al. (2020) spike protein as a consequence the main goal of this article is to present the result of the study of an interaction between (R and S)-Linezolid with receptor-binding domain (RBD) of SARS-Cov-2 spike protein complexed with human Angiostensin-converting enzyme 2 (ACE2) (6vW1 - from PDB). The Linezolid enantiomers were optimized at B3LYP/6-311++G(2d,p) level of theory. Molecular docking of the system (S)-Linezolid⋯RBD⋯ACE2 and (R)-Linezolid⋯RBD⋯ACE2 was performed, the analysis was made using LigPlot+ and NCIplot software packages, to understand the intermolecular interactions. The UV-Vis and ECD of the complexes - (R and S)-Linezolid⋯RBD⋯ACE2 were performed in two layers with DFT/6-311++G(3df,2p) and DFT/6-31G(d), respectively. The results showed that only the (S)-Linezolid had a stable interaction with − 8.05 kcal.mol(− 1), whereas all the R-enantiomeric configurations had positive values of binding energy. The (S)-Linezolid had the same interactions as in the (S)-Linezolid ⋯ Haluarcula morismortui Ribosomal system, where it is well-known the fact that the latter has biological activity. A specific interaction on the fluorine ring justified an attenuation on the ECD signal, in comparison to isolated species. Therefore, some biological activity of (S)-Linezolid with SARS-CoV-2 RBD was expected, indicated by the modification of its ECD signal and justified by a similar interaction in the S-Linezolid⋯Haluarcula marismortui Ribosomal system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00894-021-04828-8. |
format | Online Article Text |
id | pubmed-8264178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82641782021-07-08 Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study Morgon, Nelson H. Grandini, Giulia S. Yoguim, Maurício I. Porto, Caio M. Santana, Lucas C. Biswas, Srijit de Souza, Aguinaldo R. J Mol Model Original Paper The crescent evolution of a global pandemic COVID-19 and its respiratory syndrome (SARS-Cov-2) has been a constant concern (Ghosh 2021; Khan et al. 2021; Alazmi and Motwalli 2020; Vargas et al. 2020). The absence of a proven and effective medication has compelled all the scientific community to search for a new drug. The use of known drugs is a faster way to develop new therapies. Molecular docking is a powerful tool (Gao et al. J Mol Model 10: 44–54, 2004; Singh et al. J Mol Model 18: 39–51, 2012; Schulz-Gasch and Stahl J Mol Model 9:47–57, 2003) to study the interaction of potential drugs with SARS-CoV-2, Alsalme et al. (2020) and Sanders et al. (2020) spike protein as a consequence the main goal of this article is to present the result of the study of an interaction between (R and S)-Linezolid with receptor-binding domain (RBD) of SARS-Cov-2 spike protein complexed with human Angiostensin-converting enzyme 2 (ACE2) (6vW1 - from PDB). The Linezolid enantiomers were optimized at B3LYP/6-311++G(2d,p) level of theory. Molecular docking of the system (S)-Linezolid⋯RBD⋯ACE2 and (R)-Linezolid⋯RBD⋯ACE2 was performed, the analysis was made using LigPlot+ and NCIplot software packages, to understand the intermolecular interactions. The UV-Vis and ECD of the complexes - (R and S)-Linezolid⋯RBD⋯ACE2 were performed in two layers with DFT/6-311++G(3df,2p) and DFT/6-31G(d), respectively. The results showed that only the (S)-Linezolid had a stable interaction with − 8.05 kcal.mol(− 1), whereas all the R-enantiomeric configurations had positive values of binding energy. The (S)-Linezolid had the same interactions as in the (S)-Linezolid ⋯ Haluarcula morismortui Ribosomal system, where it is well-known the fact that the latter has biological activity. A specific interaction on the fluorine ring justified an attenuation on the ECD signal, in comparison to isolated species. Therefore, some biological activity of (S)-Linezolid with SARS-CoV-2 RBD was expected, indicated by the modification of its ECD signal and justified by a similar interaction in the S-Linezolid⋯Haluarcula marismortui Ribosomal system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00894-021-04828-8. Springer Berlin Heidelberg 2021-07-08 2021 /pmc/articles/PMC8264178/ /pubmed/34236527 http://dx.doi.org/10.1007/s00894-021-04828-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Morgon, Nelson H. Grandini, Giulia S. Yoguim, Maurício I. Porto, Caio M. Santana, Lucas C. Biswas, Srijit de Souza, Aguinaldo R. Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title | Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title_full | Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title_fullStr | Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title_full_unstemmed | Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title_short | Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study |
title_sort | potential activity of linezolid against sars-cov-2 using electronic and molecular docking study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264178/ https://www.ncbi.nlm.nih.gov/pubmed/34236527 http://dx.doi.org/10.1007/s00894-021-04828-8 |
work_keys_str_mv | AT morgonnelsonh potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT grandinigiulias potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT yoguimmauricioi potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT portocaiom potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT santanalucasc potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT biswassrijit potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy AT desouzaaguinaldor potentialactivityoflinezolidagainstsarscov2usingelectronicandmoleculardockingstudy |